Pan-Asia Catalysts/Events, Quiddity Advisors

David Blennerhassett

HK Type 4 license through Ballingal Investment Advisors Ltd. 

I'm a highly experienced sell-side analyst with in excess of 22 years of covering Asia Pacific equities, the past 19 years immersed in event strategies encompassing M&A risk arbitrage, directional long/short, stub trades and restructuring.  

My background also includes accountancy (liquidation/bankruptcy/receivership) earlier in my career and as a chief financial officer of a global commodity company based in the US and Mexico.

Pan-Asia Catalysts/Events

Vinda (3331 HK): That's A Wrap As Pre-Cons Done

Vinda Vs Hengan: Cut From A Different Cloth

Quiddity Advisors

Event-Driven

<ul>
<li>Tissue-Maker <strong><a href="https://www.smartkarma.com/entities/vinda-international-holdings-limited" target="_blank" data-smartkarma-citation="entities:475:1" rel="noopener">Vinda International (3331 HK)</a></strong> closed down 6.4% yesterday, recovering from a 13.8% fall intra day.</li>
<li>Vinda said its 1Q23 operating profit declined 85.4% to HK$65mn. Vinda also announced its controlling shareholder <strong><a href="https://www.smartkarma.com/entities/essity-ab" target="_blank" data-smartkarma-citation="entities:28203:1" rel="noopener">Essity (ESSITYB SS)</a></strong> will commence a strategic review of its 51.59% ownership.</li>
<li>A long-term shareholder potentially seeking a possible divestment, shortly after a company announces poor results, is not a great look.</li>
</ul>


Tissue-Maker Vinda International (3331 HK) closed down 6.4% yesterday, recovering from a 13.8% fall intra day.
Vinda said its 1Q23 operating profit declined 85.4% to HK$65mn. Vinda also announced its controlling shareholder Essity (ESSITYB SS) will commence a strategic review of its 51.59% ownership.
A long-term shareholder potentially seeking a possible divestment, shortly after a company announces poor results, is not a great look.


Vinda International

Essity Mulls Holding In Vinda (3331 HK)